EMA Withdrawn: Clopidogrel ratiopharm (clopidogrel) — Archie Samuel s.r.o.

View source ↗

Summary

Withdrawn clopidogrel product (Clopidogrel ratiopharm) listed by EMA; therapeutic areas include peripheral vascular diseases, stroke, and myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• Clopidogrel ratiopharm (clopidogrel hydrogen sulfate)

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases;Stroke;Myocardial Infarction. MAH: Archie Samuel s.r.o.. Decision date: 25/10/2013